AI platform enables optimized personalized chemotherapy

NUS AI platform enables doctors to optimise personalised chemotherapy dose


Image: Young sick woman talking to a doctor during chemotherapy; Copyright: bialasiewicz

Some patients were prescribed optimal doses that were around 20% lower on average: These early outcomes are a promising step forward for the potential of truly personalising oncology, where drug doses can be adjusted dynamically during treatment.

Weitere News auf